Diagnosing in Cardiovascular Chinese Medicine instructs readers on the finer details of cardiovascular patient examination techniques used in western medicine, together with TCM examination techniques.
Advanced Clinical Therapies in Cardiovascular Chinese Medicine is a reference on cardiovascular diseases that can be treated with Chinese medicine in both outpatient and inpatient settings in China.
The Heart and Toxins brings together global experts to provide the latest information and clinical trials that make the connection between genetic susceptibility, gene expression, and environmental factors in cardiovascular diseases.
Coronary Microvascular Obstruction in Acute Myocardial Infarction: From Mechanisms to Treatment provides a comprehensive understanding of the phenomenon of coronary microvascular obstruction (CMVO) that is the main limitation of reperfusion therapies in ST-elevation myocardial infarction.
Combining the research and study of integrative Chinese and Western Medicine, Integrative Cardiovascular Chinese Medicine: A Prevention and Personalized Medicine Perspective presents a clear, structured base to guide clinical practice and encourage collaboration between Chinese medicine and Western medicine practitioners.
Sex Differences in Cardiovascular Physiology and Pathophysiology is a comprehensive look into the often overlooked and underappreciated fundamental sex differences between men and women and how those differences affect the cardiovascular system.
This atlas depicts and describes catheter-based interventions across the entire pediatric age range, from fetal life through to early adulthood, with the aim of providing an illustrated step-by-step guide that will help the reader to master these techniques and apply them in everyday practice.
This book reflects how the concern regarding the effects of radiation exposure in patients and health personnel involved in cardiac electrophysiology (EP) has inspired new developments in cardiac electrophysiology procedures without the use of fluoroscopy.
The goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) - which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia - and to share the latest information on evolving approaches to diagnosis and treatment.
The latest edition of this practical handbook provides a concise yet comprehensive overview of common and rare problems with hemostasis and thrombosis.
This book is intended as a guide for all cardiologists who are interested in coronary imaging and physiology, a sound understanding of which is vital for the optimal performance of appropriate coronary interventions.
This extensively revised new edition comprehensively reviews the medical and surgical management of the acutely-ill child with congenital and acquired cardiac disease.
This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases.
This book describes the field of osteocardiology, an exciting and new sub-discipline within cardiovascular science, which will become the cornerstone for defining the timing and treatment of cardiovascular calcification in the future.
This extensively revised second edition traces the development of the basic concepts in cardiovascular physiology in light of the accumulated experimental and clinical evidence.
The second edition of this important work provides a broad range of cardiac CT angiography (CCTA) cases covering normal anatomy, congenital coronary anomalies, coronary artery disease, percutaneous coronary intervention, postsurgical coronary revascularization, and extra-coronary abnormalities.
This book describes the most popular topics concerning adult congenital heart disease (ACHD), especially focusing on indications and re-intervention procedures for some major ACHDs.
This book provides an introduction to the biological background of heart functioning and analyzes the various materials and technologies used for the development of microfluidic systems dedicated to cell culture, with an emphasis on cardiac cells.
This concise practical guide is designed to facilitate the clinical decision-making process by reviewing a number of cases and defining the various diagnostic and management decisions open to clinicians.
Practical Cardiovascular Hemodynamics provides an in-depth understanding of waveforms and tracings seen in various disease states as well as pathophysiology behind those findings.
Millions of people-many of them younger than we care to believe-are living in the aftermath of a heart attack, and it is vital for them to learn how to reduce the risk factors for subsequent heart problems.
The fifteenth volume of the Evidence-based Clinical Chinese Medicine series examines the management of chronic heart failure with Chinese medicine using a 'whole evidence' approach.
This volume explores the latest techniques used to study the human brain towards understanding Alzheimer's Disease and related neurodegenerative disorders.
The rapid pace of device development and complexity in applications along with a lack of concise, problem-oriented references has made it difficult for non-electrophysiologists to confidently manage patients with implanted cardiac rhythm devices (ICRDs).
This book provides a focused resource on how cardiac surgery capacity can be developed and how it assists in the sustainable development and strengthening of associated health systems.
Vascular management and care has become a truly multidisciplinary enterprise as the number of specialists involved in the treatment of patients with vascular diseases has steadily increased.
The second edition of this critical text features heavily revised chapters detailing how to approach the anesthetic and perioperative management of adult and pediatric patients with congenital heart disease.
As experimentation and clinical trials with first generation anti-angiogenic agents have yielded results and our understanding of the biology and physiology of blood and lymphatic vessels has increased, a new angiogenesis volume swiftly became a necessity.
